Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman F Staats

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Expert Review of Vaccines|February 7, 2007
Mucosal vaccine development for botulinum intoxicationKohtaro Fujihashi, Herman F Staats, Shunji Kozaki, et al.
Vaccine|July 29, 2008
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccinesJoseph M Thompson, Alan C Whitmore, Herman F Staats, et al.
Current Opinion in Pharmacology|May 30, 2018
Mast cell activators as novel immune regulatorsBrandi Johnson-Weaver, Hae Woong Choi, Soman N Abraham, et al.
Vaccine|April 16, 2013
Evaluation of vaccine-induced antibody responses: impact of new technologiesDaniel J Zaccaro, Diane K Wagener, Carol C Whisnant, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccinesSushila K Nordone, James W Peacock, Shaun M Kirwan, et al.
Vaccine|June 28, 2008
Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigenJoseph M Thompson, Alan C Whitmore, Herman F Staats, et al.
BMC Immunology|July 9, 2010
Adenovirus F protein as a delivery vehicle for botulinum BBeata Clapp, Sarah Golden, Massimo Maddaloni, et al.
Current Topics in Microbiology and Immunology|August 9, 2011
Dry powder vaccines for mucosal administration: critical factors in manufacture and deliverySheena H Wang, Afton L Thompson, Anthony J Hickey, et al.
Scientific Reports|June 14, 2024
Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccinesPedro L Sanchez, Herman F Staats, Soman N Abraham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 24, 2016
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunityKyle K L Phua, Herman F Staats, Smita K Nair, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Expert Review of Vaccines|February 7, 2007
Mucosal vaccine development for botulinum intoxicationKohtaro Fujihashi, Herman F Staats, Shunji Kozaki, et al.
Vaccine|July 29, 2008
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccinesJoseph M Thompson, Alan C Whitmore, Herman F Staats, et al.
Current Opinion in Pharmacology|May 30, 2018
Mast cell activators as novel immune regulatorsBrandi Johnson-Weaver, Hae Woong Choi, Soman N Abraham, et al.
Vaccine|April 16, 2013
Evaluation of vaccine-induced antibody responses: impact of new technologiesDaniel J Zaccaro, Diane K Wagener, Carol C Whisnant, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccinesSushila K Nordone, James W Peacock, Shaun M Kirwan, et al.
Vaccine|June 28, 2008
Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigenJoseph M Thompson, Alan C Whitmore, Herman F Staats, et al.
BMC Immunology|July 9, 2010
Adenovirus F protein as a delivery vehicle for botulinum BBeata Clapp, Sarah Golden, Massimo Maddaloni, et al.
Current Topics in Microbiology and Immunology|August 9, 2011
Dry powder vaccines for mucosal administration: critical factors in manufacture and deliverySheena H Wang, Afton L Thompson, Anthony J Hickey, et al.
Scientific Reports|June 14, 2024
Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccinesPedro L Sanchez, Herman F Staats, Soman N Abraham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 24, 2016
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunityKyle K L Phua, Herman F Staats, Smita K Nair, et al.
Pageof 8